Sands Capital Ventures, LLC Candel Therapeutics, Inc. Transaction History
Sands Capital Ventures, LLC
- $194 Million
- Q3 2024
A detailed history of Sands Capital Ventures, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 405,837 shares of CADL stock, worth $2.68 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
405,837
Previous 405,837
-0.0%
Holding current value
$2.68 Million
Previous $2.52 Million
11.76%
% of portfolio
1.45%
Previous 1.27%
Shares
3 transactions
Others Institutions Holding CADL
# of Institutions
56Shares Held
6.41MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$12.8 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$6.25 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$5.43 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$3.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$2.96 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $191M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...